Daily Bulletin


News

  • Written by Barbara Mintzes, Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney

As the world continues to battle COVID-19, the prospect of a vaccine gives us hope of returning to some kind of “normal” in the not too distant future.

The Australian government has signed supply agreements with manufacturers of four COVID vaccines currently in clinical trials. Assuming one or more meets the requirements for safety and effectiveness, everyone will be able to be vaccinated for free.

However, as vaccine supply will be limited at least initially, the government has specified certain groups that will take priority to receive vaccines first. These include people at higher risk of exposure to COVID-19 (such as health-care workers), and those who are more vulnerable to severe disease (such as older people).

At the same time, the head of the Therapeutic Goods Administration (TGA), John Skerritt, has noted manufacturers will also be able to sell vaccines privately:

We live in a free market economy […] There’s nothing stopping companies as long as they have the TGA approval to put that vaccine on the market in Australia.

Read more: 90% efficacy for Pfizer's COVID-19 mRNA vaccine is striking. But we need to wait for the full data

This arrangement reinforces the status quo of Australia’s health system: a public health system with a private market on the side. But COVID is not the status quo. It’s a global public health emergency that has already claimed more than 1.3 million lives.

Allowing people to jump the queue via the private market is a bad idea, for several reasons.

1. A private market puts wealth ahead of need

Those most likely to buy the vaccine privately are those who have not been deemed at high enough risk to receive the vaccine for free until later on, but have the means to do so (we don’t know yet how much it might cost).

Prices are often higher in the private sector because public drug schemes benefit from their size and bargaining power to keep prices low, which could lead vaccine manufacturers to prioritise private sales. If companies set aside a portion of their limited supply for private sales, people who need the vaccine the most, such as health workers and older people, may have to wait longer.

If there are exceptions where people who don’t fall into the priority categories need a vaccine, such as for essential travel to a country that mandates vaccination as a condition of entry, the answer is to build in flexibility through special access requests, not private sales.

A woman receives a vaccination from a health-care worker. If and when a COVID vaccine becomes available, older people will be towards the front of the queue. Shutterstock

2. People buying privately may not get the vaccine they need

Several vaccines may come onto the market, and we don’t yet know if all will be equally effective for everyone. For example, it’s possible a particular vaccine won’t work as well in older people.

The allure of private sales may lead companies to promote their vaccines, in turn affecting which one a patient gets. Drug companies have a long history of intensive marketing to doctors, often casting a wide net in terms of who they suggest might benefit. In the case of the opioid epidemic, these practices have been associated with serious harm to patients.

Companies cannot advertise prescription-only products, including vaccines, to the public in Australia. But they can run unbranded disease awareness campaigns that indirectly promote products to consumers, often through emotional images and appeals.

3. Follow-up may be poorer

COVID vaccine development is moving very quickly, with shorter pre-market testing than a vaccine would normally have. This makes it all the more important to keep careful track of who receives the vaccine, any health problems they experience, and longer-term effectiveness. Uncoordinated private provision creates extra logistical challenges for follow-up.

Read more: Why we should prioritise older people when we get a COVID vaccine

4. Private supply may be impractical

As an example, Pfizer’s mRNA-based vaccine must be stored at -80℃. Special cold chain management is not easy for any provider, but is likely better handled by larger-scale providers set up to deliver COVID vaccines.

Further, all COVID-19 vaccines are likely to require at least two doses. Especially if supply is limited, it may become challenging to make sure private patients get their second dose. And delays or missing the second dose will likely lead to lower effectiveness.

Illustration of 3 stick figures reaching for COVID vaccine Allowing people who have the means to purchase a COVID vaccine privately isn’t equitable. Shutterstock

An issue of equity

Some 40 countries have joined the World Health Organisation’s Solidarity Call to Action to support equitable global access to COVID-19 health technologies. Similarly, the COVAX initiative, which Australia supports, provides direct funding for vaccine access in less advantaged countries.

Echoing the principles of these initiatives, Prime Minister Scott Morrison told the United Nations in September:

[…] it’s a moral responsibility for a vaccine to be shared far and wide. Some might see short-term advantage or even profit, but I assure you, to anyone who may think along those lines, humanity will have a very long memory, and be a very, very severe judge.

Given this moral responsibility, why allow wealthier Australians to jump the queue? The planned public rollout of free COVID-19 vaccines for all is laudable. The main rationale for a parallel private system is “short-term advantage or even profit”, to borrow the prime minister’s words. Let’s not go there.

Read more: Creating a COVID-19 vaccine is only the first step. It'll take years to manufacture and distribute

Authors: Barbara Mintzes, Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney

Read more https://theconversation.com/you-may-be-able-to-buy-a-covid-vaccine-ahead-of-the-government-rollout-but-jumping-the-queue-comes-at-a-price-149972

Writers Wanted

Diverse spokespeople and humour: how the government's next ad campaign could boost COVID vaccine uptake

arrow_forward

Let's talk about what each uni does, but don't make it a choice between teaching or research

arrow_forward

The Advantages Of Using Betting Apps in Australia

arrow_forward

The Conversation
INTERWEBS DIGITAL AGENCY

Politics

Prime Minister interview with Karl Stefanovic and Allison Langdon

Karl Stefanovic: PM, good morning to you. Do you have blood on your hands?   PRIME MINISTER: No, it's obviously absurd. What we're doing here is we've got a temporary pause in place because we'v...

Karl Stefanovic and Allison Langdon - avatar Karl Stefanovic and Allison Langdon

Prime Minister Scott Morrison delivered Keynote Address at AFR Business Summit

Well, thank you all for the opportunity to come and be with you here today. Can I also acknowledge the Gadigal people, the Eora Nation, the elders past and present and future. Can I also acknowled...

Scott Morrison - avatar Scott Morrison

Morrison Government commits record $9B to social security safety net

The Morrison Government is enhancing our social security safety net by increasing support for unemployed Australians while strengthening their obligations to search for work.   From March the ...

Scott Morrison - avatar Scott Morrison

Business News

Boom in Aussies buying up restaurants, pubs, hotels and bars in regional centres

With international borders closed, regional Australia is seeing a dramatic surge in popularity as people move out of the cities and into their quaint communities. City slickers are looking for new...

Tess Sanders Lazarus - avatar Tess Sanders Lazarus

5 Signs Your Business Needs Onboarding Software

Onboarding software is the technology that automates a smooth transition for new hires from before the interview to the first day on the job. High-quality onboarding platforms feature a digital da...

Onboarded - avatar Onboarded

What Is COVID 19 Risk Assessment for Vulnerable Workers and Why Your Business Needs it

During the height of the COVID-19 pandemic, governments strongly advised people to just stay at home as a critical effort to stop the spread of the virus. This led to many businesses temporarily s...

NewsServices.com - avatar NewsServices.com